Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.
Amazon on Wednesday announced plans to shut down its telehealth venture Amazon Care by the end of 2022, STAT News reported. This announcement comes only a month after news of Amazon’s plan to acquire One Medical for $3.9 billion, and will not affect other Amazon health care projects. According to Neil Lindsay, Amazon Health Services leader, the effort “was not a complete enough offering for the large enterprise customers we have been targeting, and wasn’t going to work long-term.”
During the first year of the COVID-19 pandemic, the number of new type 2 diabetes (T2D) diagnoses among US youth rose by 77%, CIDRAP News reported. A study published in Journal of Pediatrics looked at health records of 3113 youth aged between 8 and 21 years who had COVID-19. It showed that new cases of T2D increased by 1463 patients between March 2020 and February 2021, compared with an average of 886 in 2019, and 765 in 2018. The likelihood of presenting with metabolic decompensation and severe diabetic ketoacidosis also significantly increased during this time.
Evidence from a congressional investigation revealed White House officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment, hydroxychloroquine, The Associated Press reported. The FDA had originally authorized the use of hydroxychloroquine in late March 2020 based on small study results, at a time when researchers hoped existing antiviral drugs would work against the virus, but revoked its emergency use authorization 3 months later after it was found to be ineffective and potentially harmful. According to the report, the Trump administration attempted to control the release of FDA COVID-19 guidance and establish political operatives at public health agencies. There is no evidence that these efforts changed the FDA’s decisions on approving or rejecting hydroxychloroquine or any other therapies for COVID-19.
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More
2 Commerce Drive
Cranbury, NJ 08512